Mariana Oliva
Obstetrics & Gynecology · Riverview, FLNPI 1124552724
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (58.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 66.6% of it on its own, with 32 other manufacturers making up the rest. Reporting peaked in 2024 at $4,025 and has fallen 88.5% since, to $461 in 2025.
Across 87 payments — averaging $61.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$4K
- Astellas Pharma US Inc$287
- AbbVie$200
- Sumitomo Pharma America, Inc.$136
- Gynesonics, Inc.$120
- Myovant Sciences Inc.$95
- plus $937 from 27 others
What the payments were for
- Travel & lodging$52310%
- Food & beverage$1,70632%
- Education$3,08558%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 7 | $3,540 |
| Astellas Pharma US Inc | 11 | $287 |
| AbbVie | 9 | $200 |
| Sumitomo Pharma America, Inc. | 7 | $136 |
| Gynesonics, Inc. | 2 | $120 |
| Myovant Sciences Inc. | 5 | $95 |
| Hologic Sales And Service, LLC | 4 | $87 |
| Sage Therapeutics, LLC | 4 | $87 |
| Organon | 4 | $80 |
| Mayne Pharma Commercial LLC | 4 | $79 |
| Millicent US Inc | 3 | $69 |
| Dilon Technologies, Inc. | 1 | $49 |
| Johnson & Johnson | 1 | $42 |
| Meditrina | 3 | $37 |
| Coopersurgical, Inc. | 2 | $36 |
| Scynexis, Inc. | 2 | $31 |
| Pfizer | 2 | $30 |
| Monaghan Medical Corporation | 1 | $25 |
| Idorsia Pharmaceuticals US Inc | 1 | $25 |
| Boston Scientific | 1 | $23 |
| Novo Nordisk | 1 | $23 |
| Abbott | 1 | $22 |
| Bayer | 1 | $20 |
| Optumhealth Care Solutions, LLC | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Northgate Technologies, Inc. | 1 | $18 |
| Mimedx Group, Inc. | 1 | $18 |
| Ascend Therapeutics US, LLC | 1 | $18 |
| Exeltis, USA Inc. | 1 | $17 |
| Exact Sciences | 1 | $17 |
| Amgen | 1 | $17 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Channel Medsystems, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,313 in reported general payments places this provider in the 85th percentile of 2,438 obstetrics & gynecology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ImvexxyEstradiol | 12 | $2,663 |
| Estradiol | 18 | $1,271 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Riverview
- Steven McCarusCelebration$2.3M
- Elliot CazesTampa$725K
- Charles BloomWinter Park$652K
- Jay CohenPlantation$556K
- Omar ZwainWinter Park$531K
- Keith AquaWellington$473K
- Jeffrey KotzenPalm Beach Gardens$413K
- Glenn BankertCrestview$388K
- Erica StockwellCelebration$321K
- Scott JordanFort Lauderdale$316K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.